tyrosine has been researched along with dihydropyridines in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fekete, Z; Liu, J; Murty, VL; Slomiany, A; Slomiany, BL | 1 |
Evans, GJ; Pocock, JM | 1 |
An, RH; Hofmann, F; Ito, H; Kass, RS; Klugbauer, N; Lacinová, L; Triggle, D; Xia, J | 1 |
Badou, A; Druet, P; Guéry, JC; Leclerc, C; Moreau, M; Paulet, P; Pelletier, L; Ragab-Thomas, J; Savignac, M | 1 |
Iwao, H; Kawano, H; Kim, S; Zhan, Y | 1 |
Kishimoto, C; Shioji, K; Yuan, Z | 1 |
Hoda, JC; Huber, IG; Sinnegger-Brauns, MJ; Striessnig, J; Walter-Bastl, D; Wappl-Kornherr, E | 1 |
Tikhonov, DB; Zhorov, BS | 1 |
Aung, HH; Barnholt, KE; Kota, RS; Rutledge, JC | 1 |
Dilling, WL; Jensen, AW; Mohanty, DK | 1 |
1 review(s) available for tyrosine and dihydropyridines
Article | Year |
---|---|
The growing relevance of biological ene reactions.
Topics: Ascorbic Acid; Biochemistry; Dihydropyridines; Flavins; Models, Chemical; Monoamine Oxidase; Nitric Oxide Synthase; Pyridinium Compounds; Tyrosine | 2019 |
9 other study(ies) available for tyrosine and dihydropyridines
Article | Year |
---|---|
Activation of dihydropyridine-sensitive parotid salivary gland calcium channels by epidermal growth factor.
Topics: Animals; Calcium; Calcium Channels; Calcium Radioisotopes; Cell Membrane; Dihydropyridines; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Isradipine; Lanthanum; Liposomes; Male; Parotid Gland; Phosphorylation; Rats; Rats, Sprague-Dawley; Tyrosine | 1992 |
Modulation of neurotransmitter release by dihydropyridine-sensitive calcium channels involves tyrosine phosphorylation.
Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Adhesion Molecules; Cerebellum; Dihydropyridines; Electrophysiology; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Membrane Potentials; Nerve Tissue Proteins; Nifedipine; omega-Conotoxins; Peptides; Phosphorylation; Potassium; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Time Factors; Tritium; Tyrosine; Vanadates; Vinculin | 1999 |
Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
Topics: Amino Acid Sequence; Amino Acid Substitution; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Humans; Isradipine; Kinetics; Membrane Potentials; Models, Molecular; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Protein Structure, Secondary; Recombinant Fusion Proteins; Recombinant Proteins; Threonine; Transfection; Tyrosine; Verapamil | 1999 |
Protein kinase C-mediated calcium entry dependent upon dihydropyridine sensitive channels: a T cell receptor-coupled signaling pathway involved in IL-4 synthesis.
Topics: Calcium; Calcium Channels, L-Type; Dihydropyridines; Humans; In Vitro Techniques; Interleukin-4; Phosphorylation; Protein Kinase C; Receptors, Antigen, T-Cell; Th1 Cells; Th2 Cells; Tyrosine | 2001 |
Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
Topics: Albuminuria; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Genetic Predisposition to Disease; Hypertension; Kidney Glomerulus; Male; Phosphorylation; Proteinuria; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Platelet-Derived Growth Factor beta; Stroke; Tyrosine | 2002 |
Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase.
Topics: Acute Disease; Animals; Autoimmune Diseases; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Heart Rate; Myocarditis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Inbred Lew; Tyrosine | 2003 |
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels.
Topics: Animals; Brain; Calcium; Calcium Channels; Calcium Channels, L-Type; Carrier Proteins; Cell Membrane; Dihydropyridines; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Gallopamil; Homozygote; In Situ Hybridization; Isradipine; Kinetics; Mice; Mice, Transgenic; Microsomes; Models, Biological; Mutation; Oocytes; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; RNA, Complementary; Steroid Isomerases; Tyrosine; Verapamil; Xenopus laevis | 2004 |
Structural model for dihydropyridine binding to L-type calcium channels.
Topics: Amino Acid Sequence; Binding Sites; Calcium; Calcium Channels, L-Type; Dihydropyridines; Hydrogen Bonding; Ions; Ligands; Models, Chemical; Molecular Conformation; Molecular Sequence Data; Monte Carlo Method; Protein Conformation; Structure-Activity Relationship; Tyrosine | 2009 |
Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Analgesics; Animals; Cell Line; Dihydropyridines; Gene Expression; Humans; Interferon-gamma; Janus Kinases; Macrophage Activation; Macrophages; Mice; Microarray Analysis; Phosphorylation; Quinazolines; Receptor, Adenosine A3; Serine; Signal Transduction; STAT1 Transcription Factor; Transcriptional Activation; Triazoles; Tyrosine | 2009 |